Which of the following is NOT typically associated with management of chronic graft dysfunction?

Chronic graft dysfunction is a condition that can arise in transplant patients when the transplanted organ begins to lose function over time. Effective management strategies are important for maintaining the health of both the patient and the transplanted organ.

The option related to immediate graft removal is not typically associated with the management of chronic graft dysfunction because this condition generally requires a more measured approach. Rather than removing the graft, management focuses on addressing the factors contributing to the dysfunction, including monitoring and modifying treatment regimens.

For example, managing proteinuria with ACE inhibitors is a common practice as these medications can help protect renal function and reduce protein leakage. Regular blood pressure monitoring is essential since hypertension can exacerbate graft dysfunction and affect the overall health of the transplant. Additionally, rather than stopping immunosuppressive therapy, which is crucial for preventing rejection of the graft, therapy may be adjusted based on the individual's condition and lab results.

Therefore, the approach to chronic graft dysfunction involves careful monitoring and adjustment of medication rather than immediate removal of the graft.